The aim of the present study is to evaluate the effect of eicosapentaenoic acid-docosahexaenoic acid (EPA-DHA) rich sterol ester and A-linolenic Acid (ALA) rich sterol ester on the atherogenic disturbances in hypercholesterolemic atherogenic animals. Six groups of male Wistar rats were employed in this study, wherein five groups were fed with a high cholesterol diet (stock diet supplemented with 1% cholesterol) for 30 days, among which, two groups of rats were also treated with EPA-DHA rich sterol ester in two doses (25 and 50 mg/rat/day, oral gavage) and two groups were treated with ALA rich sterol ester also in two doses (25 and 50 mg/rat/day, oral gavage). The remaining one group served as control. Abnormal increases in the levels of malondialdehyde, as well as depressed antioxidants status, were observed in hepatic tissue of hypercholesterolemic control group. Hypercholesterolemia induced abnormal elevation in the activities of marker enzymes in liver (aspartate transaminase, alanine transaminase and alkaline phosphatase) and was accompanied by increased hepatic cholesterol level and altered fatty changes in the histology of liver. These changes were restored partially in the groups administered with lower doses (25 mg/rat/day) of sterol esters. However, the higher doses (50 mg/rat/day) of sterol esters almost ameliorated the hypercholesterolemic-oxidative changes in the hypercholesterolemic rats. The results of this study present oxidative injury induced by hypercholesterolemic diet and administration of the treatment with higher doses of sterol esters afforded sound protection against lipemic-oxidative injury.